Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.
Luca AntonelliDavide ArdizzoneIsamu TachibanaNabil AdraClint CaryLee HugarWade J SextonAditya BagrodiaMichal MegoSiamak DaneshmandNicola NicolaiSebastiano NazzaniPatrizia GiannatempoAndrea FranzaAxel HeidenreichPia PaffenholzRagheed SaoudScott E EggenerMatthew HoNathaniel OswaldKathleen OlsonAlexey A TryakinMikhail Yu FedyaninNatacha NaounChristophe JavaudWalter CazzanigaDavid NicolAxel GerdtssonTorgrim TandstadKarim FizaziChristian Daniel Fankhausernull nullPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Men with a complete resection at pcRPLND and <10% viable cells have favorable outcomes without further treatment. Complete retroperitoneal resection seems more important than early pcRPLND.
Keyphrases
- papillary thyroid
- germ cell
- squamous cell
- robot assisted
- induced apoptosis
- lymph node
- prostate cancer
- lymph node metastasis
- cell cycle arrest
- type diabetes
- squamous cell carcinoma
- radical prostatectomy
- adipose tissue
- oxidative stress
- cell death
- skeletal muscle
- cell proliferation
- radiation therapy
- insulin resistance
- minimally invasive
- replacement therapy